Study of Oral LBH589 in Adult Patients With Refractory Cutaneous T-Cell Lymphoma

Novartis Investigative Site, Leuven

Novartis Investigative Site, Parkville

Novartis Investigative Site, South Brisbane

Novartis Investigative Site, Yvoir

Novartis Investigative Site, Zurich

Novartis Investigative Site, Ghent

Novartis Investigative Site, Torino

Novartis Investigative Site, Berlin

University of Pittsburgh Medical Center Department of Dermatology, Pittsburgh

Wake Forest University Baptist Medical Center OutpatientCmprehensivCancerCtr, Winston-Salem

Novartis Investigative Site, Madrid

Novartis Investigative Site, Madrid

Emory University School of Medicine/Winship Cancer Institute Dept. of Hematology (2), Atlanta

Georgia Health Sciences University Dept.ofMedicalCollegeOfGeorgia, Augusta

Novartis Investigative Site, Minden

Florida Academic Dermatology Center, Miami

Novartis Investigative Site, Bologna

University Dermatology Consultants, Cincinnati

Indiana University Dept. of IU Cancer Center, Indianapolis

University of Michigan Health System Michigan HouseClinTrialsOffice, Ann Arbor

Novartis Investigative Site, Florence

Novartis Investigative Site, Ancona

NorthwesternUniv.Med.School/Robert H. Lurie Comp.Cancer Ctr Dept. of NorthwesterUMed, Chicago

Novartis Investigative Site, Lyon

Novartis Investigative Site, Paris

MD Anderson Cancer Center/University of Texas StudyCoordinator:CLBH589B2201, Houston

Novartis Investigative Site, Napoli

University of California at Los Angeles Dept. of Hematology-Oncology, Los Angeles

Novartis Investigative Site, Créteil

Novartis Investigative Site, Würzburg

Oregon Health & Science University Dept. of OHSU Cancer Institute, Portland

University of Alabama at Birmingham/ Kirklin Clinic Kirklin Clinic, Birmingham

City of Hope National Medical Center, Duarte

Boston Medical Center StudyCoordinator:CLBH589B2201, Boston

Dana Farber Cancer Institute Deptof DanaFarberCancerInst(3), Boston

Novartis Investigative Site, CABA

Novartis Investigative Site, Buenos Aires

Novartis Investigative Site, Ottawa

Novartis Investigative Site, Montreal

Novartis Investigative Site, Helsinki

Novartis Investigative Site, Budapest

Novartis Investigative Site, Barcelona